Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emile E Voest

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
Biochimica Et Biophysica Acta|February 27, 2004
Angiogenesis: from understanding to targetingEmile E Voest
Cancer Discovery|February 7, 2016
DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?Emile E Voest, Rene Bernards
Biochimica Et Biophysica Acta|August 26, 2009
Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil?Yuval Shaked, Emile E Voest
Cancer Cell|August 20, 2021
Tumor organoids: Opportunities and challenges to guide precision medicineVivien Veninga, Emile E Voest
Progress in Molecular and Subcellular Biology|December 13, 2006
Tumor suppressors APC and VHL: gatekeepers of the intestine and kidneyRachel H Giles, Emile E Voest
Experimental Cell Research|March 23, 2013
The host immunological response to cancer therapy: An emerging concept in tumor biologyTali Voloshin, Emile E Voest, Yuval Shaked
JAMA Oncology|September 11, 2015
Let Them Eat Fish--ReplyLaura G M Daenen, Emile E Voest
The New England Journal of Medicine|July 12, 2023
Third-Line Therapy in Metastatic Colorectal CancerJoris van de Haar, Nicola Valeri, Emile E Voest
Biochimica Et Biophysica Acta|March 18, 2008
All along the watchtower: is the cilium a tumor suppressor organelle?Dorus A Mans, Emile E Voest, Rachel H Giles
The Oncologist|May 2, 2007
Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancerMaartje Los, Jeanine M L Roodhart, Emile E Voest
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
Biochimica Et Biophysica Acta|February 27, 2004
Angiogenesis: from understanding to targetingEmile E Voest
Cancer Discovery|February 7, 2016
DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?Emile E Voest, Rene Bernards
Biochimica Et Biophysica Acta|August 26, 2009
Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil?Yuval Shaked, Emile E Voest
Cancer Cell|August 20, 2021
Tumor organoids: Opportunities and challenges to guide precision medicineVivien Veninga, Emile E Voest
Progress in Molecular and Subcellular Biology|December 13, 2006
Tumor suppressors APC and VHL: gatekeepers of the intestine and kidneyRachel H Giles, Emile E Voest
Experimental Cell Research|March 23, 2013
The host immunological response to cancer therapy: An emerging concept in tumor biologyTali Voloshin, Emile E Voest, Yuval Shaked
JAMA Oncology|September 11, 2015
Let Them Eat Fish--ReplyLaura G M Daenen, Emile E Voest
The New England Journal of Medicine|July 12, 2023
Third-Line Therapy in Metastatic Colorectal CancerJoris van de Haar, Nicola Valeri, Emile E Voest
Biochimica Et Biophysica Acta|March 18, 2008
All along the watchtower: is the cilium a tumor suppressor organelle?Dorus A Mans, Emile E Voest, Rachel H Giles
The Oncologist|May 2, 2007
Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancerMaartje Los, Jeanine M L Roodhart, Emile E Voest
Pageof 24